首页> 外国专利> Compositions and methods involving the site ii nuclear hormone receptors.

Compositions and methods involving the site ii nuclear hormone receptors.

机译:涉及II位核激素受体的组合物和方法。

摘要

A method for evaluating the potential of a chemical entity to bind to Site II of a glucocorticoid receptor (GR) comprising: (a) docking a chemical entity into the cavity circumscribed by said GR Site II, wherein said GR site II is a structure defined by structure coordinates that describe the backbone atoms of the conserved residues having a standard deviation no greater than 2.0 Å relative to the main chain atoms of the conserved residues described by the structure coordinates of E537-V543, L566, G567, Q570-W577, S599-A607, W610, R611, R614, Q615, P625, Y663, L664 and K667 of GR amino acids as shown in Figure 2 according to Table I, Table IV or Table V; (B) analyze the complementarity of structural and chemical characteristics between said chemical entity and said GR Site II; and (c) screening the chemical entity in an in vitro assay that characterizes binding to said GR Site II, thereby identifying the chemical entity as a modulator.
机译:一种用于评估化学实体与糖皮质激素受体(GR)的位点II结合的潜力的方法,该方法包括:(a)将化学实体对接至所述GR位点II所包围的腔中,其中所述GR位点II是定义的结构通过结构坐标描述相对于E537-V543,L566,G567,Q570-W577,S599的结构坐标描述的保守残基主链原子的标准偏差不大于2.0Å的保守残基的骨架原子-A607,W610,R611,R614,Q615,P625,Y663,L664和K667的GR氨基酸,如表2,表IV或表V所示; (B)分析所述化学实体和所述GR站点II之间的结构和化学特性的互补性; (c)在表征与所述GR位点II结合的体外试验中筛选化学实体,从而鉴定该化学实体为调节剂。

著录项

  • 公开/公告号ES2337679T3

    专利类型

  • 公开/公告日2010-04-28

    原文格式PDF

  • 申请/专利权人 BRISTOL-MYERS SQUIBB COMPANY;

    申请/专利号ES20030765637T

  • 发明设计人 DOWEYKO ARTHUR;NADLER STEVEN G.;

    申请日2003-07-17

  • 分类号G01N33/74;G06F19/16;

  • 国家 ES

  • 入库时间 2022-08-21 18:43:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号